The MET axis as a therapeutic target

This publication has 103 references indexed in Scilit:

• Expression and mutational analysis of MET in human solid cancers
  Genes, Chromosomes and Cancer, 2008
• High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
  Blood, 2008
• A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras
  Molecular Cancer Therapeutics, 2008
• Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion
  Cancer Research, 2008
• MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
  Proceedings of the National Academy of Sciences, 2007
• MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
  Science, 2007
• EGFR targeting therapies: Monoclonal antibodies versus tyrosine kinase inhibitors
  Critical Reviews in Oncology/Hematology, 2007
• A C. elegans Model of Nicotine-Dependent Behavior: Regulation by TRP-Family Channels
  Cell, 2006
• Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development
  Oncogene, 2001
• Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
  Nature, 1987